Erythropoietin (Y-shaped pegylation, Xiamen Amoytop Biotech)
Y型PEG化重组人促红素（厦门特宝）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameErythropoietin (Y-shaped pegylation, Xiamen Amoytop Biotech)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[5]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesXiamen Amoytop Biotech Co LtdBiogeneric Pharma
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A